Loading...
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
Liu, Jinbiao Meng, Fengzhen Khan, Adil I. Wang, Xu Saribas, Sami Wang, Tao Lohani, Saroj Chandra Wang, Peng Wei, Zhengyu
Liu, Jinbiao
Meng, Fengzhen
Khan, Adil I.
Wang, Xu
Saribas, Sami
Wang, Tao
Lohani, Saroj Chandra
Wang, Peng
Wei, Zhengyu
Citations
Altmetric:
Genre
Journal article
Date
2021-08-31
Advisor
Committee member
Group
Department
Pathology and Laboratory Medicine
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1186/s13578-021-00680-8
Abstract
Background: As the COVID-19 pandemic rages on, the new SARS-CoV-2 variants have emerged in the different regions of the world. These newly emerged variants have mutations in their spike (S) protein that may confer resistance to vaccine-elicited immunity and existing neutralizing antibody therapeutics. Therefore, there is still an urgent need of safe, effective, and affordable agents for prevention/treatment of SARS-CoV-2 and its variant infection. Results: We demonstrated that green tea beverage (GTB) or its major ingredient, epigallocatechin gallate (EGCG), were highly effective in inhibiting infection of live SARS-CoV-2 and human coronavirus (HCoV OC43). In addition, infection of the pseudoviruses with spikes of the new variants (UK-B.1.1.7, SA-B.1.351, and CA-B.1.429) was efficiently blocked by GTB or EGCG. Among the 4 active green tea catechins at noncytotoxic doses, EGCG was the most potent in the action against the viruses. The highest inhibitory activity was observed when the viruses or the cells were pre-incubated with EGCG prior to the infection. Mechanistic studies revealed that EGCG blocked infection at the entry step through interfering with the engagement of the receptor binding domain (RBD) of the viral spikes to angiotensin-converting enzyme 2 (ACE2) receptor of the host cells. Conclusions: These data support further clinical evaluation and development of EGCG as a novel, safe, and cost-effective natural product for prevention/treatment of SARS-CoV-2 transmission and infection.
Description
Citation
Liu, J., Bodnar, B.H., Meng, F. et al. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell Biosci 11, 168 (2021). https://doi.org/10.1186/s13578-021-00680-8
Citation to related work
BMC
Has part
Cell and Bioscience, Vol. 11, No. 168
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu